Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cimminiello

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Haematologica|April 3, 2002
Peripheral arterial disease as global vascular risk factorC Cimminiello
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Choice of low molecular weight heparinsC Cimminiello
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Is aspirin effective in diabetic patients? NoC Cimminiello
Lancet (London, England)|August 30, 2000
PEP trial. Pulmonary Embolism PreventionC Cimminiello
Lancet (London, England)|July 3, 1993
Tissue-type plasminogen activator and risk of myocardial infarctionC Cimminiello
Thrombosis Research|October 3, 2002
PAD. Epidemiology and pathophysiologyC Cimminiello
Seminars in Thrombosis and Hemostasis|January 1, 1996
Clinical trials with defibrotide in vascular disordersC Cimminiello
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2005
Management of ischaemic stroke: statins and antiplatelet agentsC Cimminiello, A Romano
Diabetologia|November 1, 1996
Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?C Cimminiello, M Milani
Minerva Cardioangiologica|February 18, 1999
[Indices of leukocyte activation in post-thrombophlebitic syndrome]G Arpaia, P Bernasconi, C Cimminiello
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Haematologica|April 3, 2002
Peripheral arterial disease as global vascular risk factorC Cimminiello
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Choice of low molecular weight heparinsC Cimminiello
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Is aspirin effective in diabetic patients? NoC Cimminiello
Lancet (London, England)|August 30, 2000
PEP trial. Pulmonary Embolism PreventionC Cimminiello
Lancet (London, England)|July 3, 1993
Tissue-type plasminogen activator and risk of myocardial infarctionC Cimminiello
Thrombosis Research|October 3, 2002
PAD. Epidemiology and pathophysiologyC Cimminiello
Seminars in Thrombosis and Hemostasis|January 1, 1996
Clinical trials with defibrotide in vascular disordersC Cimminiello
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2005
Management of ischaemic stroke: statins and antiplatelet agentsC Cimminiello, A Romano
Diabetologia|November 1, 1996
Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?C Cimminiello, M Milani
Minerva Cardioangiologica|February 18, 1999
[Indices of leukocyte activation in post-thrombophlebitic syndrome]G Arpaia, P Bernasconi, C Cimminiello
Pageof 6